Preparation method and application of series of functional conjugated nanoring containing ring-p-phenylene skeleton
Patent Information
- Application Number
- CN202410752446.3
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-06-12
- Publication Date
- 2024-11-12
AI Technical Summary
[0003]本发明针对CPPs的化学也面临着一些问题:(1)由于其未取代的苯基元而限制了CPPs的种类和数量; (2) CPPs的结构特征阻碍了它们的后期修饰,使CPPs的功能化变得困难,提供了一种简便、高效、通用的合成方法,利用预保留修饰基团的策略,以原料易得的联苯芳烃衍生物为前驱体,发展系列新型CPPs衍生物,为进一步探索新材料、新应用奠定坚实的基础
[0032] The positive effects of the preparation method and application of a series of functional conjugated nanorings containing ring paraphenylene skeleton disclosed in the present invention are:
Smart Images

Figure FT_1 
Figure FT_2 
Figure FT_3
Abstract
Description
Technical Field
[0001] The invention belongs to the synthesis and derivatization of supramolecular macrocycles, in particular to a universal method for synthesizing cycloparaphenylene skeleton conjugated nanorings and derivatives thereof. Background Art
[0002] Cycloparaphenylene (CPPs) is a typical class of conjugated nanorings, which are formed by multiple connections of benzene rings at the para position. They can be regarded as the smallest component of armchair carbon nanotubes and can also be used as seeds for the chemical synthesis of carbon nanotubes. In the past decade, CPPs chemistry has flourished and attracted widespread attention from synthetic chemists, and a variety of synthetic methods have been continuously optimized. With the development of CPPs synthetic chemistry, some practical applications of CPPs in the fields of materials science and supramolecular chemistry have been realized, such as bioimaging, optoelectronic functional materials, porous materials, supramolecular recognition and assembly, mechanical interlocking molecules, etc. Although the synthesis methods of CPPs are constantly developing, the chemistry of CPPs also faces some problems: (1) the types and quantities of CPPs are limited due to their unsubstituted phenyl elements; (2) the structural characteristics of CPPs hinder their later modification, making the functionalization of CPPs difficult. In this context, the development of a precise and controllable synthesis strategy for CPP skeleton conjugated nanorings has important theoretical and practical significance. Summary of the invention
[0003] The present invention also faces some problems in the chemistry of CPPs: (1) the types and quantities of CPPs are limited due to their unsubstituted phenyl elements; (2) the structural characteristics of CPPs hinder their later modification, making the functionalization of CPPs difficult. A simple, efficient and universal synthesis method is provided. By using the strategy of pre-reserving the modifying groups and taking biphenyl aromatic derivatives with readily available raw materials as precursors, a series of new CPPs derivatives are developed, laying a solid foundation for further exploration of new materials and new applications. The present invention designs acetoxy-substituted polyphenyl monomer molecules, which are further reacted with polyformaldehyde under the catalysis of Lewis acid to obtain a series of acetoxy-substituted biphenyl aromatic macrocycles in high yield. Further alkaline hydrolysis and trifluoromethylsulfonyl esterification reactions are performed to obtain a series of trifluoromethylsulfonyl ester functionalized biphenyl aromatic macrocycles. These functionalized macrocycles can be efficiently converted into new functional conjugated nanorings containing a ring-p-phenylene skeleton in the presence of a nickel catalyst.
[0004] To achieve the above purpose, the present invention discloses the following technical contents: A general method for synthesizing cycloparaphenylene skeleton conjugated nanorings and their derivatives, characterized by having the following structure: (1) Construction of a series of acetoxy-substituted polyphenyl monomer molecules; (2) Synthesis of a series of acetoxy-substituted biphenyl aromatic macrocycles; (3) Synthesis of a series of trifluoromethylsulfonyl ester-functionalized biphenyl aromatic macrocycles; (4) Efficient synthesis of a series of functional conjugated nanorings containing cycloparaphenylene skeletons; (5) Efficient post-modification of functional conjugated nanorings containing a cycloparaphenylene backbone.
[0005] in: (1) Construction of acetoxy-substituted polyphenyl monomer molecules:
[0006] The general structural formula of acetoxy-substituted polyphenyl monomer molecules
[0007] Among them, CSx is not limited to the listed structures, and can be perylene, pyrene, carbazole derivatives, and corannulene with a higher degree of conjugation.
[0008] (2) Synthesis of a series of acetoxy-substituted biphenyl aromatic macrocycles;
[0009]
[0010] in: a. CSx is not limited to the listed structures, but can be more conjugated perylene, pyrene, carbazole derivatives, and corannulene.
[0011] b. When it is CS1, n = 0 ~ 4; when it is CS2, n = 1 ~ 5; when it is CS3, n = 0 ~ 2; when it is CS4, n = 0~ 2; when it is CS5, n = 0 ~ 2; when it is CS6, n = 0 ~ 1; when it is CS7, n = 0 ~ 1; when it is CS8, n = 0.
[0012] c. When it is CS1 and CS2, n = 1; when it is CS1 and CS3, n = 1; when it is CS4 and CS5, n = 0.
[0013] (3) Synthesis of a series of trifluoromethylsulfonyl ester functionalized biphenyl aromatic macrocycles
[0014]
[0015] in: a. CSx is not limited to the listed structures, but can be more conjugated perylene, pyrene, carbazole derivatives, and corannulene.
[0016] b. When it is CS1, n = 0 ~ 4; when it is CS2, n = 1 ~ 5; when it is CS3, n = 0 ~ 2; when it is CS4, n = 0~ 2; when it is CS5, n = 0 ~ 2; when it is CS6, n = 0 ~ 1; when it is CS7, n = 0 ~ 1; when it is CS8, n = 0.
[0017] c. When it is CS1 and CS2, n = 1; when it is CS1 and CS3, n = 1; when it is CS4 and CS5, n = 0.
[0018] (4) Efficient synthesis of a series of functional conjugated nanorings containing cycloparaphenylene skeletons
[0019]
[0020] in: a. CSx is not limited to the listed structures, but can be more conjugated perylene, pyrene, carbazole derivatives, and corannulene.
[0021] b. When it is CS1, n = 0 ~ 4; when it is CS2, n = 1 ~ 5; when it is CS3, n = 0 ~ 2; when it is CS4, n = 0~ 2; when it is CS5, n = 0 ~ 2; when it is CS6, n = 0 ~ 1; when it is CS7, n = 0 ~ 1; when it is CS8, n = 0.
[0022] c. When it is CS1 and CS2, n = 1; when it is CS1 and CS3, n = 1; when it is CS4 and CS5, n = 0.
[0023] The present invention further discloses a method for synthesizing biphenyl aromatic monomers, biphenyl aromatic macrocycles and derivative compounds thereof, which are characterized in that: acetoxy-substituted polyphenyl monomer molecules are designed through Suzuki coupling reaction; further reacted with polyformaldehyde under the catalysis of Lewis acid to obtain a series of acetoxy-substituted biphenyl aromatic macrocycles in high yield. Subsequently, after alkaline hydrolysis and trifluoromethylsulfonyl esterification, a series of trifluoromethylsulfonyl ester functionalized biphenyl aromatic macrocycles are obtained. These functionalized macrocycles can be efficiently converted into new functional conjugated nanocycles containing a ring paraphenylene skeleton in the presence of a nickel catalyst.
[0024] Its characteristics include the following: (1) Construction of a series of acetoxy-substituted polyphenyl monomer molecules; (2) Synthesis of a series of acetoxy-substituted biphenyl aromatic macrocycles; (3) Synthesis of a series of trifluoromethylsulfonyl ester-functionalized biphenyl aromatic macrocycles; (4) Efficient synthesis of a series of functional conjugated nanorings containing cycloparaphenylene skeletons; (5) Efficient post-modification of functional conjugated nanorings containing a cycloparaphenylene backbone.
[0025] in: (1) The synthesis method of acetoxy-substituted polyphenyl monomer molecules is as follows: Add 4-bromo-3-methoxyphenol (60.91 g), N, N-dimethylformamide (200 mL), pyridine (35 mL) and acetyl chloride (28 mL) to a 500 mL two-necked flask and react at room temperature for 3 hours. After quenching with water, extract with dichloromethane, wash the organic phase with water three times, dry the organic phase with anhydrous sodium sulfate, and concentrate under reduced pressure. Mix the sample with silica gel and separate it by silica gel column chromatography to obtain 2-bromo-5-acetoxyanisole as a white solid (66.1 g).
[0026] Add aryl diboronic acid di(pinacol ester) (4.06 g), 2-bromo-5-acetoxyanisole (5.12 g), Pd(dppf)Cl2 (1.00 g), K2CO3 (5.25 g), 1, 4-dioxane (80 mL), H2O (20 mL) to a 250 mL round-bottom flask and reflux at 105 °C for 48 h under argon protection. Remove the solvent under reduced pressure and concentrate, add ultra-dry DMF (50 mL), pyridine (6.0 mL) and acetyl chloride (4.8 mL) to the reaction system and react at room temperature for 2 h. Quench with water, extract with dichloromethane, dry the organic phase with anhydrous sodium sulfate, concentrate under reduced pressure, mix with silica gel, and purify by silica gel column chromatography to obtain the monomer as a white solid.
[0027] (2) The synthesis method of acetoxy-substituted biphenyl aromatic macrocycle is as follows: The monomer (800 mg), paraformaldehyde (70 mg), and dichloromethane (100 mL) were added to a 250 mL round-bottom flask, and boron trifluoride etherate (2 mL) was added under stirring, and the mixture was reacted at room temperature for 2 h. After quenching with saturated sodium bicarbonate solution, the mixture was extracted with dichloromethane, and the organic phase was dried over anhydrous sodium sulfate, concentrated under reduced pressure, and separated by silica gel column chromatography to obtain three-membered rings, four-membered rings, five-membered rings, six-membered rings, and seven-membered rings, all of which were white solids.
[0028] (3) The synthesis method of a series of trifluoromethylsulfonyl ester functionalized biphenyl aromatic macrocycles is as follows: Add acetoxy-substituted biphenyl aromatic macrocycle (130 mg), sodium hydroxide (110 mg), purified water (0.3 mL), tetrahydrofuran (8 mL) to a 25 mL round-bottom flask and heat to reflux at 90°C for 2.5 h. Concentrate under reduced pressure and separate by silica gel column chromatography. Add the obtained solid to a 50 mL round-bottom flask, then add dichloromethane (10 mL), pyridine (1.5 mL) and trifluoromethanesulfonic anhydride (1.2 mL) and move to room temperature for 1 h. Slowly add water to quench, extract with dichloromethane, dry the organic phase with anhydrous sodium sulfate, separate by silica gel column chromatography, and obtain trifluoromethylsulfonyl ester functionalized biphenyl aromatic macrocycle as a white solid.
[0029] (4) The efficient synthesis method of a series of functional conjugated nanorings containing a cycloparaphenylene skeleton is as follows: Add nickel catalyst, 2, 2'-bipyridine and N-methylpyrrolidone (20 mL) to a 50 mL reaction tube. Heat at 85°C, add trifluoromethylsulfonyl ester functionalized biphenyl aromatic macrocycle, and react for 4 to 12 hours. Cool the reaction to room temperature, extract with dichloromethane and distilled water, dry the organic phase with anhydrous sodium sulfate, concentrate under reduced pressure, and separate by silica gel column chromatography to obtain functional conjugated nanorings containing a cycloparaphenylene skeleton.
[0030] (5) The efficient post-modification synthesis method of functional conjugated nanorings containing a cycloparaphenylene skeleton is as follows: Add the functional conjugated nanoring containing the cycloparaphenylene skeleton and dichloromethane (5 mL) to a 10 mL reaction tube, then add boron tribromide and react at room temperature for 3 h. Quench the reaction with distilled water, dry the organic phase with anhydrous sodium sulfate, concentrate under reduced pressure, and separate it by silica gel column chromatography to obtain a crude product for use. Add the crude product to a 10 mL round-bottom flask, add ethyl bromoacetate and potassium carbonate in sequence, reflux for 3 hours, and separate the ester-modified conjugated nanoring by column chromatography.
[0031] The present invention discloses a general method for synthesizing a cycloparaphenylene skeleton conjugated nanoring and its derivatives, which mainly comprises: a series of acetoxy-substituted biphenyl aromatic macrocycles are obtained in high yield by a one-pot method by reacting acetoxy-substituted polyphenyl monomer molecules with polyformaldehyde under the catalysis of Lewis acid. In addition, a series of trifluoromethylsulfonyl ester functionalized biphenyl aromatic macrocycles are obtained through alkaline hydrolysis and trifluoromethylsulfonyl esterification. Taking the
[10] CPP skeleton conjugated nanoring as an example, its selective molecular recognition properties for C60 and C70 are studied. The results show that, unlike the traditional
[10] CPP recognition of C60, this new type of functional conjugated nanoring containing a cycloparaphenylene skeleton exhibits a strong recognition ability for C70, and the complexation constant reaches 2.3× 10 4 M -1 Therefore, the synthetic innovation of these functional conjugated nanorings will provide unlimited vitality and vigor for the research of future functional materials.
[0032] The preparation method and application of the series of functional conjugated nanorings containing a cycloparaphenylene skeleton disclosed in the present invention have the following positive effects: The rich variety of raw materials for synthesizing acetoxy-substituted polyphenyl monomer molecules makes the types of acetoxy-substituted biphenyl aromatic macrocycles very diverse and interesting.
[0033] The synthesis of acetoxy-substituted biphenyl aromatic macrocycles from polybiphenyl monomer molecules is very simple and has high yield.
[0034] For the first time, a new macrocyclic derivatization method was invented that uses acetoxy as the positioning group to achieve rapid protection and efficient removal.
[0035] Hybrid biphenyl aromatic macrocycles were synthesized by combining acetoxy-substituted polyphenyl monomer molecules in pairs.
[0036] The derivatized trifluoromethylsulfonyl ester-functionalized biphenyl aromatic macrocycle can be efficiently converted into a new functional conjugated nanoring containing a cycloparaphenylene skeleton with a yield of more than 90% in the presence of a nickel catalyst.
[0037] Using a simple post-modification strategy, functional conjugated nanorings containing a cycloparaphenylene skeleton substituted with ester groups were obtained.
[0038] Different from the traditional
[10] CPP recognition of C60, this new class of functional conjugated nanorings containing a cyclophenylene skeleton showed strong recognition ability for C70, with a complexation constant of 2.3 × 10 4 M -1 Therefore, the synthetic innovation of these functional conjugated nanorings will provide unlimited vitality and vigor for the research of future functional materials. BRIEF DESCRIPTION OF THE DRAWINGS
[0039] Figure 1 . Absorption spectrum and emission spectrum of conjugated nanorings containing cycloparaphenylene skeleton; A is the ultraviolet absorption spectrum and B is the fluorescence emission spectrum; Figure 2 . H NMR spectrum of a 1:1 mixture of C60, C70 and
[10] CPP backbone; Figure 3 . Fluorescence titration of C60 and
[10] CPP backbone; Figure 4 . Fluorescence titration of C70 and
[10] CPP backbones. DETAILED DESCRIPTION Unless otherwise specified, the technical means used in the present invention are methods known to those skilled in the art. In addition, the embodiments should be understood as illustrative rather than limiting the scope of the present invention, and the essence and scope of the present invention are limited only by the claims. For those skilled in the art, various changes or modifications to the material components and dosages in these embodiments, without departing from the essence and scope of the present invention, also fall within the scope of protection of the present invention. The raw materials and reagents used in the present invention are all commercially available (purchased from Bid Pharmaceuticals).
[0040] Aryl diboronic acid bis(pyranoline) esters {Synthesis method: Add dibromo-substituted raw materials (1,4-dibromobenzene, 4,4`-dibromobiphenyl, 1,4-dibromonaphthalene, 9,10-dibromoanthracene, 2,7-dibromofluorene, 2,7-dibromobenzothiophene, 2,7-dibromofluorenone) (6.14 mmol), biboronic acid pinacol ester (4.68 g, 18.42 mmol), Pd(dppf)Cl2 (10% mmol, 449 mg), KOAc (1.81 g, 18.42 mmol), 1, 4-dioxane (80 mL) into a 250 mL round-bottom flask and reflux at 100 °C for 48 h. The solvent is removed under reduced pressure and concentrated, the sample is mixed with silica gel, and separated by silica gel column chromatography to obtain the product aryl diboronic acid bipyranol ester as a white solid} and 4-bromo-3-methoxyphenyl acetate for Suzuki coupling reaction to obtain acetoxy-substituted polyphenyl monomer molecules (named MCS1~MCS8). Subsequently, it and polyformaldehyde are used as raw materials, halogenated alkanes are used as solvents, and Lewis acids are used as catalysts to react to obtain acetoxy-substituted biphenyl aromatic macrocycles. Through further derivatization, trifluoromethylsulfonyl ester functionalized biphenyl aromatic macrocycles can be obtained. Finally, a functional conjugated nanoring containing a cyclophenylene skeleton is obtained by intramolecular aryl-aryl coupling. It includes the following steps: Step 1: Construction of a series of acetoxy-substituted polyphenyl monomer molecules; Step 2: Synthesis of a series of acetoxy-substituted biphenyl aromatic macrocycles; Step 3: Synthesis of a series of trifluoromethylsulfonyl ester functionalized biphenyl aromatic macrocycles; Step 4: Efficient synthesis of a series of functional conjugated nanorings containing a cycloparaphenylene skeleton; Step 5: Efficient post-modification of functional conjugated nanorings containing a cycloparaphenylene backbone.
[0041] After the preferred embodiments are described in detail, those familiar with the technology can clearly understand that various changes and modifications can be made without departing from the scope and spirit of the above patent application, and any simple modification, equivalent change and modification made to the above embodiments according to the technical essence of the present invention are within the scope of the technical solution of the present invention. The present invention is not limited to the example implementation methods given in the specification. Example
[0042] Step 1, the synthesis method of acetoxy-substituted polyphenyl monomer molecules is as follows:
[0043]
[0044] General method for synthesizing monomeric MCSx: Add 4-bromo-3-methoxyphenol (60.91 g), N, N-dimethylformamide (200 mL), pyridine (35 mL) and acetyl chloride (28 mL) to a 500 mL two-necked flask and react at room temperature for 3 hours. After quenching with water, extract with dichloromethane, wash the organic phase with water three times, dry the organic phase with anhydrous sodium sulfate, and concentrate under reduced pressure. Mix the sample with silica gel and separate it by silica gel column chromatography to obtain 2-bromo-5-acetoxyanisole as a white solid (66.1 g).
[0045] In a 250 mL round-bottom flask, aryl diboronic acid di(pinacol ester) (4.06 g), 2-bromo-5-acetoxyanisole (5.12 g), Pd(dppf)Cl2 (1.00 g), K2CO3 (5.25 g), 1, 4-dioxane (80 mL), H2O (20 mL) were added and refluxed at 105 °C for 48 h under argon protection. The solvent was removed under reduced pressure and concentrated, and ultra-dry DMF (50 mL), pyridine (6.0 mL) and acetyl chloride (4.8 mL) were added to the reaction system and reacted at room temperature for 2 h. Water was added to quench, and the mixture was extracted with dichloromethane. The organic phase was dried over anhydrous sodium sulfate, concentrated under reduced pressure, mixed with silica gel, and purified by silica gel column chromatography to obtain the monomer MCSx as a white solid.
[0046] For MCS1: 1H NMR (400 MHz, CDCl3, 298 K) δ 7.54 (s, 4H), 7.36 (d, J =8.2 Hz, 2H), 6.78 (dd, J = 8.2, 2.2 Hz, 2H), 6.74 (d, J = 2.2 Hz, 2H), 3.82(s, 6H), 2.34 (s, 6H). 13 C NMR (101 MHz, CDCl3, 298 K) δ 169.7, 157.3, 151.0,136.6, 131.3, 129.3, 128.3, 113.8, 105.3, 55.8, 21.3. HRMS (ESI) m / z : [MCS1] •+ Calcd for C 24 H 22 O6 •+ 406.1411; found 406.1415; [MCS1+NH4] + Calcd for C 24 H 26 NO6 + 424.1755; found 424.1756. For MCS2: 1 H NMR (400 MHz, CDCl3, 298 K) δ 7.67 (d, J = 8.3 Hz, 4H),7.59 (d, J = 8.2 Hz, 4H), 7.37 (d, J = 8.2 Hz, 2H), 6.80 (dd, J = 8.2, 2.1Hz, 2H), 6.75 (d, J = 2.1 Hz, 2H), 3.84 (s, 6H), 2.34 (s, 6H). 13 C NMR (101MHz, CDCl3, 298 K) δ 169.72, 157.29, 151.07, 139.74, 136.88, 131.26, 130.01,128.08, 126.92, 113.81, 105.34, 77.16, 55.87, 21.33. HRMS (ESI) m / z : [MCS2]•+ Calcd for C 30 H 26 O6 •+ 482.1724; found 482.1730. For MCS3: 1 H NMR (400 MHz, CDCl3, 298 K) δ 7.67 – 7.59 (m, 2H), 7.42(d, J = 2.0 Hz, 2H), 7.39-7.33 (m, 3H), 7.30 (d, J = 8.0 Hz, 1H), 6.83 (d, J = 8.2 Hz, 2H), 6.81 (d, J = 1.8 Hz, 2H), 3.71 (s, 6H), 2.37 (s, 6H). 13 C NMR(101 MHz, CDCl3, 298 K) δ 169.7, 158.0, 158.0, 151.3, 135.9, 135.8, 132.42,132.40, 132.23, 132.22, 127.3, 127.1, 126.6, 125.48, 113.43, 113.4, 105.1,55.8, 55.7, 21.3. HRMS (ESI) m / z : [MCS3] •+ Calcd for C 28 H 24 O6 •+ 456.1567; found456.1577; [MCS3+NH4] + Calcd for C 28 H 28 NO6 + 474.1911; found 474.1913. For MCS4: 1 H NMR (400 MHz, CDCl3, 298 K) δ 7.82 (d, J = 7.9 Hz, 2H),7.67 (s, 2H), 7.52 (d, J = 7.9 Hz, 2H), 7.38 (d, J = 8.2 Hz, 2H), 6.79 (dd, J= 8.3, 1.7 Hz, 2H), 6.75 (s, 2H), 3.98 (s, 2H), 3.83 (s, 6H), 2.34 (s, 6H). 13 CNMR (101 MHz, CDCl3, 298 K) δ 169.7, 157.3, 150.9, 143.5, 140.7, 136.4,131.4, 128.9, 128.4, 126.2, 119.6, 113.8, 105.4, 55.9, 37.2, 21.4. HRMS (ESI) m / z : [MCS4] •+ Calcd for C 31 H 26 O6 •+ 494.1724; found 494.1734. For MCS5: 1 H NMR (400 MHz, CDCl3, 298 K) δ 8.17 (d, J = 8.2 Hz, 2H),7.98 (s, 2H), 7.61 (d, J = 8.3 Hz, 2H), 7.41 (d, J = 8.2 Hz, 2H), 6.82 (dd, J = 8.2, 1.9 Hz, 2H), 6.77 (d, J = 1.9 Hz, 2H), 3.84 (s, 6H), 2.35 (s, 6H). 13 CNMR (101 MHz, CDCl3, 298 K) δ 169.7, 157.4, 151.2, 139.8, 136.5, 134.4,131.6, 128.2, 126.4, 123.7, 121.1, 113.9, 105.5, 55.9, 21.4. HRMS (ESI) m / z :[MCS5] •+ Calcd for C 30 H 24 O6S •+ 512.1288; found 512.1294. For MCS6: 1 H NMR (400 MHz, CDCl3, 298 K) δ 7.96 (d,<h2 style=";text-align:left;direction:ltr"> J <h2 style=";text-align:left;direction:ltr"> = 8.0 Hz, 2H),7.74 (d,<h2 style=";text-align:left;direction:ltr"> J <h2 style=";text-align:left;direction:ltr"> = 1.0 Hz, 2H), 7.49 (dd,<h2 style=";text-align:left;direction:ltr"> J <h2 style=";text-align:left;direction:ltr"> = 8.0, 1.4 Hz, 2H), 7.41 (d,<h2 style=";text-align:left;direction:ltr"> J <h2 style=";text-align:left;direction:ltr"> = 8.2Hz, 2H), 6.82 (dd,<h2 style=";text-align:left;direction:ltr"> J <h2 style=";text-align:left;direction:ltr"> = 8.2, 2.2 Hz, 2H), 6.77 (d,<h2 style=";text-align:left;direction:ltr"> J <h2 style=";text-align:left;direction:ltr"> = 2.1 Hz, 2H), 3.84 (s,6H), 2.35 (s, 6H).<h2 style=";text-align:left;direction:ltr"> 13 <h2 style=";text-align:left;direction:ltr"> C NMR (101 MHz, CDCl3, 298 K) δ 169.68, 157.31, 156.68,151.21, 137.10, 131.59, 128.31, 124.59, 123.19, 120.12, 113.89, 112.83,105.49, 77.16, 55.91, 21.34. HRMS (ESI)<h2 style=";text-align:left;direction:ltr"> m / z <h2 style=";text-align:left;direction:ltr"> : [MCS6]<h2 style=";text-align:left;direction:ltr"> •+ <h2 style=";text-align:left;direction:ltr"> Calcd for C<h2 style=";text-align:left;direction:ltr"> 30 <h2 style=";text-align:left;direction:ltr"> H<h2 style=";text-align:left;direction:ltr"> 24 <h2 style=";text-align:left;direction:ltr"> O7<h2 style=";text-align:left;direction:ltr"> •+ <h2 style=";text-align:left;direction:ltr"> 496.1517; found 496.1526.<h2 style=";text-align:left;direction:ltr"> <h2 style=";text-align:left;direction:ltr"> For MCS7:<h2 style=";text-align:left;direction:ltr"> 1 <h2 style=";text-align:left;direction:ltr"> H NMR (400 MHz, CDCl3, 298 K) δ 7.83 (s, 2H), 7.63 (d,<h2 style=";text-align:left;direction:ltr"> J <h2 style=";text-align:left;direction:ltr"> =7.6 Hz, 2H), 7.56 (d,<h2 style=";text-align:left;direction:ltr"> J <h2 style=";text-align:left;direction:ltr"> = 7.7 Hz, 2H), 7.35 (d,<h2 style=";text-align:left;direction:ltr"> J <h2 style=";text-align:left;direction:ltr"> = 8.2 Hz, 2H), 6.80 (dd,<h2 style=";text-align:left;direction:ltr"> J <h2 style=";text-align:left;direction:ltr"> = 8.2, 2.0 Hz, 2H), 6.75 (d,<h2 style=";text-align:left;direction:ltr"> J <h2 style=";text-align:left;direction:ltr"> = 1.9 Hz, 2H), 3.83 (s, 6H), 2.34 (s, 6H).<h2 style=";text-align:left;direction:ltr"> 13 <h2 style=";text-align:left;direction:ltr"> CNMR (101 MHz, CDCl3, 298 K) δ 194.1, 169.6, 157.3, 151.5, 143.1, 138.9,135.9, 134.6, 130.9, 127.2, 125.7, 120.2, 113.9, 105.4, 55.9, 21.3. HRMS(ESI)m / z : [MCS7+H] + Calcd for C 31 H 25 O7 + 509.1595; found 509.1600. For MCS8: 1 H NMR (400 MHz, CDCl3, 298 K) δ 7.84 (dd, J = 6.8, 3.3 Hz,4H), 7.76 (d, J = 8.2 Hz, 4H), 7.53 (d, J = 1.6 Hz, 2H), 7.51 (d, J = 1.6 Hz,2H), 7.37 (dd, J = 6.9, 3.2 Hz, 4H), 6.87 (dd, J = 8.2, 2.2 Hz, 2H), 6.82 (d, J = 2.1 Hz, 2H), 3.92 (s, 6H), 2.37 (s, 6H). HRMS (ESI) m / z : [MCS8+H] + Calcdfor C 44 H 35 O6 + 659.2428; found 659.2443.
[0047] Add paraformaldehyde (120 mg, 4.0 mmol) to a solution of MCS1 (203 mg, 0.5 mmol) and dichloromethane (50 mL) and stir at room temperature for 5 minutes. Then add boron trifluoride etherate (0.50 mL) and stir at room temperature for 60 minutes. Quench the reaction with saturated NaHCO3 solution (80 mL) and stir vigorously for 3.0 hours. Dry the organic phase with anhydrous Na2SO4. Silica gel column chromatography with PE / EA (V:V= 1:1 as eluent to obtain the product BP[n]-CS1-2nOAc as a white solid.
[0048] For BP[3]-CS1-6OAc: 1H NMR (400 MHz, CDCl3, 298 K) δ 7.41(s,12H),7.03(s,6H), 6.65(s,6H), 3.76(s,18H), 3.68(s,6H), 2.31(s,18H). 13 CNMR (101 MHz, CDCl3, 298 K) δ 169.5, 155.8, 148.7, 136.4, 132.5, 129.3,128.6, 123.8, 105.7, 55.9, 28.9, 21.0. HRMS (ESI): m / z calcd for [BP[3]-CS1-6OAc+K] + , C 75 H 66 O 18 K + , 1293.3881, found For BP[4]-CS1-8OAc: 1 H NMR (400 MHz, CDCl3, 298 K) δ 7.41(s,16H),7.02(s,8H), 6.65(s,8H), 3.75(s,24H), 3.68(s,8H), 2.28(s,24H). 13 CNMR (101 MHz, CDCl3, 298 K) δ 169.6, 155.8, 148.7, 136.4, 132.5, 129.3,128.6, 123.6, 105.7, 55.9, 28.9, 21.0. HRMS (ESI): m / z calcd for [BP[4]-CS1-8OAc+K] + , C 100 H 88 O 24 K + , 1711.5297, found For BP[5]-CS1-10OAc: 1 H NMR (400 MHz, CDCl3, 298 K) δ 7.43 (s, 20H), 7.06 (s, 10H), 6.65 (s, 10H), 3.73 (s, 30H), 3.70 (s, 10H), 2.26 (s, 30H).13 CNMR (101 MHz, CDCl3, 298 K) δ 169.5, 155.7, 148.7, 136.4, 132.5, 129.2,128.5, 123.7, 105.78, 77.16, 55.81, 29.34, 20.97. HRMS (MALDI-TOF): m / z calcdfor [BP[5]-CS1-10OAc] •+ , C 125 H 110 O 30 •+ , 2090.7076, found 2090.7065.
[0049] Add paraformaldehyde (120 mg, 4.0 mmol) to a solution of MCS2 (240 mg, 0.5 mmol) in dichloromethane (50 mL) and stir at room temperature for 5 minutes. Then add boron trifluoride etherate (0.5 mL) and stir at room temperature for 2 hours. Quench the reaction with saturated NaHCO3 solution (80 mL). Dry the organic phase over anhydrous Na2SO4. Silica gel column chromatography with PE / EA (V: V= 1:1 as eluent gives the pure product BP[n]-CS2-2nOAc as a white solid.
[0050] For BP[3]-CS2-6OAc: 1 H NMR (400 MHz, CDCl3, 298 K) δ 7.60 (d, J = 8.3Hz, 12H), 7.52 (d, J = 8.3 Hz, 12H), 7.09 (s, 6H), 6.69 (s, 6H), 3.81 (s,18H), 3.73 (s, 6H), 2.33 (s, 18H). 13 HRMS (MALDI-TOF): m / z calcd for [BP[3]-CS2-6OAc] •+ , C 93 H73 O 18 •+ ,1482.5183, found For BP[4]-CS2-8OAc: 1 H NMR (400 MHz, CDCl3, 298 K) δ 7.59 (d J = 8.3Hz, 16H), 7.51(d, J = 8.3 Hz, 16H), 7.07(s, 8H), 6.70(s, 8H), 3.80(s,24H), 3.74(s, 8H), 2.30(s, 24H). 13 C NMR (101 MHz, CDCl3, 298 K) δ 169.6,155.8; 21.0. HRMS (ESI): m / z calcd for [BP[4]-CS2-8OAc+Na] + , C 124 H 104 NaO 24 + ,1999.6810, found 1999.6852. For BP[5]-CS2-10OAc: 1 H NMR (400 MHz, CDCl3, 298 K) δ 7.61 (d, J = 8.4Hz, 20H), 7.52 (d, J = 8.3 Hz, 20H), 7.12 (s, 10H), 6.69 (s, 10H), 3.79 (s,30H), 3.75 (s,30H). 10H), 2.28(s, 30H). 13 C NMR (101 MHz, CDCl3, 298 K) δ 169.5. 21.0. HRMS (ESI): m / z calcd for [BP[5]-CS2-10OAc+Na] + , C155 H 130 NaO 30 + ,2493.8539, found 2493.8504. For BP[6]-CS2-12OAc: 1 H NMR (400 MHz, CDCl3, 298 K) δ 7.61 (d, J = 8.3Hz, 24H), 7.53 (d, J = 8.3 Hz, 24H), 7.12 (s, 12H), 6.69 (s, 12H), 3.76 (s,36H), 3.75 (s, 12H), 2.27 (s, 36H). 13 C NMR (101 MHz, CDCl3, 298 K) δ 169.5,155.7, 148.9, 139.6, 136.7, 132.5, 130.0, 128.3, 126.8, 123.7, 105.9, 55.9,29.5, 21.0. HRMS (ESI): m / z calcd for [BP[6]-CS2-12OAc + Na] + , C 186 H 156 NaO 36 + ,2988.0269, found 2988.0266. For BP[7]-CS2-14OAc: 1 H NMR (400 MHz, CDCl3, 298 K) δ 7.60 (d, J = 8.3Hz, 28H), 7.52 (d, J = 8.3 Hz, 28H), 7.12 (s, 14H), 6.68 (s, 14H), 3.77 (s,42H), 3.74 (s, 14H), 2.26 (s, 42H). 13 C NMR (101 MHz, CDCl3, 298 K) δ 169.5,155.8, 148.9, 139.7, 136.8, 132.5, 130.0, 128.3, 126.9, 123.8, 106.0, 55.9,29.6, 21.0. HRMS (ESI): m / zcalcd for [BP[7]-CS2-14OAc + Na] + , C 217 H 182 NaO 42 + ,3482.1998, found 3482.1901.
[0051] In MCS3 (240 mg, 0.5 mmol), dichloromethane (50 mL), paraformaldehyde (120 mg, 4.0mmol), stir at room temperature for 5 minutes. Then add boron trifluoride etherate (0.5 mL) and stir at room temperature for 2 hours. Quench the reaction with saturated NaHCO3 solution (80 mL). Dry the organic phase with anhydrous Na2SO4. Silica gel column chromatography with PE / EA (V: V= 1:1 as eluent to obtain the pure product BP[n]-CS3-2nOAc as a white solid.
[0052] For BP[3]-CS3-6OAc: 1 H NMR (400 MHz, CDCl3, 298 K) δ 7.41 (s, 12H), 7.03 (s, 6H), 6.65 (s, 6H), 3.76 (s, 18H), 3.68 (s, 6H), 2.31 (s, 18H). 13 CNMR (101 MHz, CDCl3, 298 K) δ 169.5, 155.8, 148.7, 136.4, 132.5, 129.3,128.6, 123.8, 105.7, 55.9, 28.9, 21.0. HRMS (MALDI-TOF): m / z calcd for [BP[3]-CS3-6OAc] •+ , C 87 H 72 O 18 •+ , 1404.4713, found 1404.4710. For BP[4]-CS3-8OAc: 1 H NMR (400 MHz, CDCl3, 298 K) δ 7.41 (s, 12H), 7.03 (s, 6H), 6.65 (s, 6H), 3.76 (s, 18H), 3.68 (s, 6H), 2.31 (s, 18H).13 CNMR (101 MHz, CDCl3, 298 K) δ 169.5, 155.8, 148.7, 136.4, 132.5, 129.3,128.6, 123.8, 105.7, 55.9, 28.9, 21.0. HRMS (MALDI-TOF): m / z calcd for [BP[3]-CS2-6OAc] •+ , C 93 H 73 O 18 •+ , 1482.5183, found 1482.5169.
[0053] In MCS4 (240 mg, 0.5 mmol), dichloromethane (50 mL), paraformaldehyde (120 mg, 4.0mmol), stir at room temperature for 5 minutes. Then add boron trifluoride etherate (0.5 mL) and stir at room temperature for 2 hours. Quench the reaction with saturated NaHCO3 solution (80 mL). Dry the organic phase with anhydrous Na2SO4. Silica gel column chromatography with PE / EA (V: V= 1:1 as eluent to obtain the pure product BP[n]-CS4-2nOAc as a white solid.
[0054] For BP[2]-CS4-4OAc: 1 H NMR (400 MHz, CDCl3, 298 K) δ 7.79 (d, J = 7.9Hz, 4H), 7.62 (d, J = 7.9 Hz, 4H), 7.39 (s, 4H), 7.32 (s, 4H), 6.70 (s, 4H), 3.83 (s, 12H), 3.73 (s, 4H), 3.60 (s, 4H), 2.42 (s, 12H). 13 C NMR (101 MHz, CDCl3, 298 K) δ 169.6, 155.6, 148.4, 143.6, 140.6, 136.7, 133.5, 128.9,128.1, 126.3, 123.0, 119.6, 105.7, 58.7, 55.9, 21.1, 18.6. HRMS (MALDI-TOF): m / z calcd for [BP[2]-CS4-4OAc]•+ , C 64 H 52 O 12 •+ , 1012.3453, found 1012.3454. For BP[3]-CS4-6OAc: 1 H NMR (400 MHz, CDCl3, 298 K) δ 7.41 (s, 12H), 7.03 (s, 6H), 6.65 (s, 6H), 3.76 (s, 18H), 3.68 (s, 6H), 2.31 (s, 18H). 13 CNMR (101 MHz, CDCl3, 298 K) δ 169.5, 155.8, 148.7, 136.4, 132.5, 129.3,128.6, 123.8, 105.7, 55.9, 28.9, 21.0. HRMS (MALDI-TOF): m / z calcd for [BP[3]-CS2-6OAc] •+ , C 93 H 73 O 18 •+ , 1482.5183, found 1482.5169.
[0055] In MCS5 (240 mg, 0.5 mmol), dichloromethane (50 mL), paraformaldehyde (120 mg, 4.0mmol), stir at room temperature for 5 minutes. Then add boron trifluoride etherate (0.5 mL) and stir at room temperature for 2 hours. Quench the reaction with saturated NaHCO3 solution (80 mL). Dry the organic phase with anhydrous Na2SO4. Silica gel column chromatography with PE / EA (V: V= 1:1 as eluent to obtain the pure product BP[n]-CS5-2nOAc as a white solid.
[0056] For BP[2]-CS5-4OAc: 1 H NMR (400 MHz, CDCl3, 298 K) δ 8.13 (d, J = 8.1Hz, 4H), 7.67 (d, J= 8.0 Hz, 4H), 7.58 (s, 4H), 7.50 (s, 4H), 6.71 (s, 4H),3.84 (s, 12H), 3.75 (s, 4H), 2.44 (s, 12H). 13 C NMR (101 MHz, CDCl3, 298 K) δ169.5, 155.7, 148.6, 140.4, 136.6, 134.4, 133.6, 128.4, 125.5, 123.9, 123.1,121.2, 105.9, 56.0, 26.4, 21.1. HRMS (MALDI-TOF): m / z calcd for [BP[2]-CS5-4OAc] •+ , C 62 H 48 O 12 S2 •+ , 1048.2582, found 1048.2578. For BP[3]-CS5-6OAc: 1 H NMR (400 MHz, CDCl3, 298 K) δ 7.41 (s, 12H),7.03 (s, 6H), 6.65 (s, 6H), 3.76 (s, 18H), 3.68 (s, 6H), 2.31 (s, 18H). 13 CNMR (101 MHz, CDCl3, 298 K) δ 169.5, 155.8, 148.7, 136.4, 132.5, 129.3,128.6, 123.8, 105.7, 55.9, 28.9, 21.0. HRMS (MALDI-TOF): m / z calcd for [BP[3]-CS5-6OAc] •+ , C 93 H 73 O 18 •+ , 1482.5183, found 1482.5169.
[0057] In MCS6 (240 mg, 0.5 mmol), dichloromethane (50 mL), paraformaldehyde (120 mg, 4.0mmol), stir at room temperature for 5 minutes. Then add boron trifluoride etherate (0.5 mL) and stir at room temperature for 2 hours. Quench the reaction with saturated NaHCO3 solution (80 mL). Dry the organic phase with anhydrous Na2SO4. Silica gel column chromatography with PE / EA (V: V= 1:1 as eluent to obtain the pure product BP[n]-CS6-2nOAc as a white solid.
[0058] For BP[2]-CS6-4OAc: 1 H NMR (400 MHz, Acetone- d 6, 298 K) δ 8.09 – 7.99(m, 1H), 7.76 (d, J = 6.6 Hz, 1H), 7.57 – 7.46 (m, 1H), 7.43 (d, J = 8.3 Hz,1H), 7.32 (d, J = 2.8 Hz, 1H), 6.93 (s, 1H), 6.89 – 6.76 (m, 1H), 3.92 – 3.64 (m, 5H), 2.84 (s, 4H). 13 C NMR (101 MHz, CDCl3, 298 K) δ 169.5, 155.8, 148.7,136.4, 132.5, 129.3, 128.6, 123.8, 105.7, 55.9, 28.9, 21.0. HRMS (MALDI-TOF): m / z calcd for [BP[3]-CS6-6OAc] •+ , C 93 H 73 O 18 •+ , 1482.5183, found 1482.5169.
[0059] In MCS7 (240 mg, 0.5 mmol), dichloromethane (50 mL), paraformaldehyde (120 mg, 4.0mmol), stir at room temperature for 5 minutes. Then add boron trifluoride etherate (0.5 mL) and stir at room temperature for 6 hours. Quench the reaction with saturated NaHCO3 solution (80 mL) and stir vigorously for 3.0 hours. Quench the reaction with saturated NaHCO3 solution (80 mL). Dry the organic phase with anhydrous Na2SO4. Silica gel column chromatography with PE / EA (V: V= 1:3 as eluent to obtain the pure product BP[n]-CS7-2nOAc as a white solid.
[0060] For BP[2]-CS7-4OAc: 1 H NMR (400 MHz, CDCl3, 298 K) δ 7.74 (dd, J =7.7, 1.6 Hz, 4H), 7.54 (d, J = 7.7 Hz, 4H), 7.45 (d, J = 1.3 Hz, 4H), 7.35(s, 4H), 6.68 (s, 4H), 3.81 (s, 12H), 3.70 (s, 4H), 2.41 (s, 12H). 13 C NMR(101 MHz, CDCl3, 298 K) δ 169.4, 155.8, 148.8, 143.2, 138.8, 135.4, 135.2,132.9, 127.9, 125.5, 123.4, 120.0, 106.1, 56.0, 21.0. HRMS (MALDI-TOF): m / z calcd for [BP[2]-CS7-6OAc] •+ , C 93 H 73 O 18 •+ , 1482.5183, found 1482.5169. For BP[3]-CS7-6OAc: 1 H NMR (400 MHz, CDCl3, 298 K) δ 7.78 (s, 6H), 7.50 (s, 12H), 7.04 (s, 6H), 6.69 (s, 6H), 3.80 (s, 18H), 3.72 (s, 6H), 2.32(s, 18H). 13C NMR (101 MHz, CDCl3, 298 K) δ 169.4, 155.9, 149.3, 143.1, 138.7,135.9, 134.5, 132.1, 127.7, 125.8, 123.9, 120.3, 106.1, 56.0, 21.0. HRMS(MALDI-TOF): m / z calcd for [BP[3]-CS7-6OAc] •+ , C 96 H 72 O 21 •+ , 1560.4561, found1560.4545.
[0061] In MCS8 (0.5 mmol), dichloromethane (50 mL), paraformaldehyde (120 mg, 4.0 mmol), stir at room temperature for 5 minutes. Then add boron trifluoride etherate (0.5 mL) and stir at room temperature for 2 hours. Quench the reaction with saturated NaHCO3 solution (80 mL). Dry the organic phase with anhydrous Na2SO4. Silica gel column chromatography with PE / EA (V: V= 1:1 as eluent to obtain the pure product BP[2]-CS8-4OAc as a white solid.
[0062] For BP[2]-CS8-4OAc: 1 H NMR (400 MHz, CDCl3, 298 K) δ 7.81 (s, 4H),7.73 (d, J = 8.0 Hz, 8H), 7.65 (dd, J = 6.8, 3.3 Hz, 8H), 7.38 (d, J = 8.0Hz, 8H), 6.99 (dd, J = 6.9, 3.2 Hz, 8H), 6.75 (s, 4H), 3.91 (s, 12H), 3.84(s, 4H), 2.50 (s, 12H). HRMS (MALDI-TOF): m / z calcd for [BP[2]-CS8-4OAc] •+ ,C 90 H 69 O 12 + , 1341.4784, found 1341.4788.
[0063] BP[n]-CS1-2nOAc (0.3 mmol), NaOH (400 mg, 10.0 mmol), water (5.0 mL) and THF (20 mL) were added to a 50 mL flask. Under argon protection, the reaction mixture was stirred at 85 ° C for 2 h. After cooling to room temperature, the solvent was removed under reduced pressure and diluted HCl (5%, 10 mL) was added to the flask. Extracted with DCM / EA. After the organic phase was concentrated, it was separated by silica gel column chromatography (DCM: EA = 1:5) to obtain the pure product BP[n]-CS1-2nOH.
[0064] For BP[3]-CS1-6OH: 1 H NMR (400 MHz, Acetone- d 6, 298 K) δ 8.96 (s, OH,6H), 7.38 (s, 12H), 7.13 (s, 6H), 6.62 (s, 6H), 3.92 (s, 6H), 3.72 (s, 18H). 13 C NMR (101 MHz, Acetone- d 6, 298 K) δ 156.9, 155.4, 137.5, 132.9, 129.6,123.2, 120.4, 100.5, 55.6, 55.5. HRMS (MALDI-TOF): m / z Calcd for [BP[3]-CS1-6OH] •+ , C 63 H 54 O 12 •+ , 1002.3610, found 1002.3613. For BP[4]-CS1-8OH: 1 H NMR (400 MHz, DMSO- d 6, 298 K) δ 9.52 (s, 1H), 7.24 (s, 2H), 6.81 (s, 1H), 6.53 (s, 1H), 3.73 (s, 1H), 3.65 (s, 3H). 13 C NMR (101 MHz, DMSO- d6, 298 K) δ 155.26, 155.00, 136.23, 131.44, 128.51, 120.28,119.25, 99.56, 99.23, 55.29, HRMS (MALDI-TOF): m / z Calcd for [BP[4]-CS1-8OH] •+ ,C 884 H 72 O 16 •+ , 1336.4815, found 1336.4808.
[0065] BP[n]-CS2-2nOAc (0.3 mmol), NaOH (400 mg, 10.0 mmol), water (5.0 mL) and THF (20 mL) were added to a 50 mL flask. Under argon protection, the reaction mixture was stirred at 85 °C for 2 h. After cooling to room temperature, the solvent was removed under reduced pressure and diluted HCl (5%, 10 mL) was added to the flask. Extracted with DCM / EA. After the organic phase was concentrated, silica gel column chromatography (DCM: EA = 1:10) was used to obtain the product BP[n]-CS2-2nOH.
[0066] For BP[3]-CS2-6OH: 1 H NMR (400 MHz, Acetone- d 6, 298 K) δ 8.87 (s, OH,6H), 7.64 (d, J = 8.3 Hz, 12H), 7.53 (d, J = 8.2 Hz, 12H), 7.25 (s, 6H), 6.66 (s, 6H), 3.98 (s, 6H), 3.76 (s, 18H). 13 C NMR (101 MHz, Acetone- d 6, 298 K) δ157.0, 155.7, 139.3, 138.6, 132.9, 130.6, 126.9, 122.8, 120.5, 100.6, 55.9,55.5, 29.8. HRMS (MALDI-TOF): m / z Calcd for [BP[3]-CS2-6OH] •+ , C 81 H66 O 12 •+ ,1230.4549, found 1230.4544.
[0067] BP[n]-CS1-2nOAc, NaOH, water (5.0 mL) and THF (20 mL) were added to a 50 mL flask. Under argon protection, the reaction mixture was stirred at 85 °C for 2 h. After cooling to room temperature, the solvent was removed under reduced pressure and diluted HCl (5%, 10 mL) was added to the flask. Extraction with DCM / EA and simple column separation of the organic phase gave a mixture of BP[n]-CS1-2nOH. Subsequently, the mixture BP[n]-CS1-2nOH and pyridine (2.0 mL) were dissolved in DCM (30 mL) and trifluoromethanesulfonic anhydride (Tf2O, 1.6 mL) was added at 0 °C. The reaction was allowed to react at room temperature for 2 h and quenched with water (10 mL). The organic phase was dried over anhydrous sodium sulfate. Silica gel column chromatography was performed using PE / DCM (V: V= 1:1) as the eluent to give the product BP[n]-CS1-2nOTf.
[0068] For BP[3]-CS1-6OTf: 1 H NMR (400 MHz, CDCl3, 298 K) δ 7.40 (s, 12H), 7.05 (s, 6H), 6.90 (s, 6H), 4.10 (s, 6H), 3.82 (s, 18H). 19 F NMR (376 MHz, CDCl3, 298 K) δ -73.58. 13 C NMR (101 MHz, CDCl3, 298 K) δ 156.4, 147.4, 136.0,133.0, 130.7, 129.3, 123.4, 120.4, 117.2, 105.1, 56.2, 28.3. HRMS (MALDI-TOF): m / z calcd for [BP[3]-CS1-6OTf] •+ , C 69 H 48 F 18 O 24 S6 •+ , 1794.0567, found1794.0548. For BP[4]-CS1-8OTf: 1H NMR (400 MHz, CDCl3, 298 K) δ 7.39(s,16H),7.02(s,8H), 6.88(s,8H), 4.09(s,8H), 3.81(s,24H). 19 F NMR (376 MHz, CDCl3, 298 K) δ-73.56. 13 C NMR (101 MHz, CDCl3, 298 K) δ 156.3, 147.3,136.00, 133.1, 130.9, 129.3, 123.5, 120.4, 117.2, 105.0, 56.2, 28.1. HRMS(MALDI-TOF): m / z calcd for [BP[4]-CS1-8OTf] •+ , C 92 H 64 F 24 O 32 S8 •+ , 2392.0758, found2 For BP[5]-CS1-10OTf: 1 H NMR (400 MHz, CDCl3, 298 K) δ 7.41(s,20H),7.07(s,10H), 6.88(s,10H), 4.09(s,10H), 3.77(s,30H). 19 F NMR (376 MHz, CDCl3, 298 K) δ-73.60. 13 C NMR (101 MHz, CDCl3, 298 K) δ 156.3, 147.3, 136.0, 133.1, 130.8, 129.3, 123.4, 120.3, 117.1, 105.1, 56.1, 28.4. HRMS (MALDI-TOF): m / z calcd for [BP[5]-CS1-10OTf] •+ , C 115 H 80 F 30 O 40 S 10 •+ , 2990.0948, found2 For BP[6]-CS1-12OTf:1 H NMR (400 MHz, CDCl3, 298 K) δ 7.41 (s, 24H), 7.09 (s, 12H), 6.87 (s, 12H), 4.08 (s, 12H), 3.75 (s, 36H). 19 F NMR (376 MHz, CDCl3, 298 K) δ -73.61. 13 C NMR (101 MHz, CDCl3, 298 K) δ 156.4, 147.3, 136.0,133.1, 130.9, 129.3, 123.5, 120.4, 117.2, 105.1, 56.1, 28.7. HRMS (MALDI-TOF): m / z calcd for [BP[6]-CS1-12OTf] •+ , C 138 H 96 F 36 O 48 S 12 •+ , 2990.0948, found2990.0952.
[0069] BP[n]-CS2-2nOAc, NaOH, water (5.0 mL) and THF (20 mL) were added to a 50 mL flask. Under argon protection, the reaction mixture was stirred at 85 °C for 2 h. After cooling to room temperature, the solvent was removed under reduced pressure and diluted HCl (5%, 10 mL) was added to the flask. Extraction with DCM / EA and simple column separation of the organic phase gave a mixture of BP[n]-CS2-2nOH. Subsequently, the mixture BP[n]-CS2-2nOH and pyridine (2.0 mL) were dissolved in DCM (30 mL) and trifluoromethanesulfonic anhydride (Tf2O, 1.6 mL) was added at 0 °C. The reaction was allowed to react at room temperature for 2 h and quenched with water (10 mL). The organic phase was dried over anhydrous sodium sulfate. Silica gel column chromatography was performed using PE / DCM (V: V= 1:1) as the eluent to give the product BP[n]-CS2-2nOTf.
[0070] For BP[3]-CS2-6OTf: 1 H NMR (400 MHz, CDCl3, 298 K) δ 7.62 (d, J = 8.3Hz, 12H), 7.49 (d, J= 8.3 Hz, 12H), 7.10(s, 6H), 6.94(s, 6H), 4.14(s,6H), 3.86(s, 18H). 19 F NMR (376 MHz, CDCl3, 298 K) δ-73.57. 13 C NMR (101 MHz,CDCl3, 298 K) 156.4, 147.4, 140.0, 135.9, 132.9, 130.7, 130.0, 127.0, 123.3, 120.3, 117.2, 105.2, 56.2, 28.4. HRMS (MALDI-TOF): m / z calcd for [BP[3]-CS2-6OTf] •+ , C 87 H 60 F 18 O 24 S6 •+ , 2022.1506, found For BP[4]-CS2-8OTf: 1 H NMR (400 MHz, CDCl3, 298 K) J = 8.2Hz, 16H), 7.49(d, J = 8.3 Hz, 16H), 7.09(s, 8H), 6.92(s, 8H), 4.13(s,8H), 3.85(s, 24H). 19 F NMR (376 MHz, CDCl3, 298 K) δ-73.55. 13 C NMR (101 MHz,CDCl3, 298 K) δ 156.32, 147.32, 140.05, 135.78, 132.94, 130.84; HRMS (MALDI-TOF): 105.05, 77.16, 56.22, 28.23. m / z calcd for [BP[4]-CS2-8OTf] •+ , C 116 H 80 F 24 O 32 S8 •+, 2696.2010, found2 For BP[5]-CS2-10OTf: 1 H NMR (400 MHz, CDCl3, 298 K) δ 7.61 (d J = 8.3Hz, 20H), 7.49(d, J = 8.2 Hz, 20H), 7.13(s,10H), 6.92(s,10H), 4.13(s,10H), 3.83(s,30H). 19 F NMR (376 MHz, CDCl3, 298 K) δ-73.55. 13 C NMR (101MHz, CDCl3, 298 K) 156.4, 147.3; HRMS (MALDI-TOF): m / z calcd for [BP[5]-CS2-10OTf] •+ , C 145 H 100 F 30 O 40 S 10 •+ , 3370.2513, found For BP[6]-CS2-12OTf: 1 H NMR (400 MHz, CDCl3, 298 K) δ 7.62 (d J = 8.2Hz, 24H), 7.50(d, J = 8.2 Hz, 24H), 7.15(s, 12H), 6.91(s, 12H), 4.13(s,12H), 3.81(s, 36H). 19 F NMR (376 MHz, CDCl3, 298 K) δ-73.54. 13C NMR (101MHz, CDCl3, 298 K) δ 156.3, 147.2, 140.0, 135.7, 133.0, 130.7, 129.9, 126.9,123.4, 120.2, 117.1, 105.0, 56.1, 28.5. HRMS (MALDI-TOF): m / z calcd for [BP[6]-CS2-12OTf] •+ , C 174 H 120 F 36 O 48 S 12 •+ , 4044.3017, found 4044.3032. For BP[7]-CS2-14OTf: 1 H NMR (400 MHz, CDCl3, 298 K) δ 7.61 (d, J = 8.3Hz, 28H), 7.49 (d, J = 8.3 Hz, 28H), 7.15 (s, 14H), 6.90 (s, 14H), 4.12 (s,14H), 3.81 (s, 42H). 19 F NMR (376 MHz, CDCl3, 298 K) δ -73.55. 13 C NMR (101MHz, CDCl3, 298 K) δ 156.3, 147.3, 140.0, 135.8, 133.1, 130.8, 130.0, 127.0,123.4, 120.3, 117.1, 105.0, 56.2, 28.6.
[0071] BP[n]-CS4-2nOAc, NaOH, water (5.0 mL) and THF (20 mL) were added to a 50 mL flask. Under argon protection, the reaction mixture was stirred at 85 °C for 2 h. After cooling to room temperature, the solvent was removed under reduced pressure and diluted HCl (5%, 10 mL) was added to the flask. Extraction with DCM / EA and simple column separation of the organic phase gave a mixture of BP[n]-CS4-2nOH. Subsequently, the mixture BP[n]-CS4-2nOH and pyridine (2.0 mL) were dissolved in DCM (30 mL) and trifluoromethanesulfonic anhydride (Tf2O, 1.6 mL) was added at 0 °C. The reaction was allowed to react at room temperature for 2 h and quenched with water (10 mL). The organic phase was dried over anhydrous sodium sulfate. Silica gel column chromatography was performed using PE / DCM (V: V= 1:1) as the eluent to give the product BP[n]-CS4-2nOTf.
[0072] For BP[2]-CS4-4OTf: 1 H NMR (400 MHz, CDCl3, 298 K) δ 7.83 (d, J = 7.9Hz, 4H), 7.62 (d, J = 7.9 Hz, 4H), 7.43 (s, 4H), 7.28 (s, 4H), 6.94 (s, 4H), 4.16 (s, 4H), 3.88 (s, 12H), 3.56 (s, 4H). 19 F NMR (376 MHz, CDCl3, 298 K) δ -73.42. 13 C NMR (101 MHz, CDCl3, 298 K) δ 156.1, 146.9, 143.6, 141.0, 135.8,133.8, 131.0, 128.2, 126.1, 122.5, 120.4, 119.9, 117.2, 105.3, 56.2, 36.9,26.6. HRMS (MALDI-TOF): m / z calcd for [BP[2]-CS4-4OTf] •+ , C 60 H 40 F 12 O 16 S4 •+ ,1372.1002, found 1372.1001.
[0073] BP[n]-CS5-2nOAc, NaOH, water (5.0 mL) and THF (20 mL) were added to a 50 mL flask. Under argon protection, the reaction mixture was stirred at 85 °C for 2 h. After cooling to room temperature, the solvent was removed under reduced pressure and diluted HCl (5%, 10 mL) was added to the flask. Extraction with DCM / EA and simple column separation of the organic phase gave a mixture of BP[n]-CS5-2nOH. Subsequently, the mixture BP[n]-CS5-2nOH and pyridine (2.0 mL) were dissolved in DCM (30 mL) and trifluoromethanesulfonic anhydride (Tf2O, 1.6 mL) was added at 0 °C. The reaction was allowed to react at room temperature for 2 h and quenched with water (10 mL). The organic phase was dried over anhydrous sodium sulfate. Silica gel column chromatography was performed using PE / DCM (V: V= 1:1) as the eluent to give the product BP[n]-CS5-2nOTf.
[0074] For BP[2]-CS5-4OTf: 1 H NMR (400 MHz, CDCl3, 298 K) δ 8.18 (d, J = 8.2Hz, 4H), 7.68 (dd, J = 8.2, 1.4 Hz, 4H), 7.62 – 7.48 (m, 8H), 6.97 (s, 4H), 4.18 (s, 4H), 3.90 (s, 12H). 19 F NMR (376 MHz, CDCl3, 298 K) δ -73.35. 13 C NMR(101 MHz, CDCl3, 298 K) δ 156.2, 147.1, 140.6, 135.8, 134.8, 133.9, 130.5,125.6, 123.8, 122.5, 121.5, 120.4, 117.2, 105.5, 56.3, 29.9. HRMS (MALDI-TOF): m / z calcd for [BP[2]-CS5-4OTf] •+ , C 58 H 36 F 12 O 16 S6 •+ , 1408.0130, found1408.0129.
[0075] BP[n]-CS7-2nOAc, NaOH, water (5.0 mL) and THF (20 mL) were added to a 50 mL flask. Under argon protection, the reaction mixture was stirred at 85 °C for 2 h. After cooling to room temperature, the solvent was removed under reduced pressure and diluted HCl (5%, 10 mL) was added to the flask. Extraction with DCM / EA and simple column separation of the organic phase gave a mixture of BP[n]-CS7-2nOH. Subsequently, the mixture BP[n]-CS7-2nOH and pyridine (2.0 mL) were dissolved in DCM (30 mL) and trifluoromethanesulfonic anhydride (Tf2O, 1.6 mL) was added at 0 °C. The reaction was allowed to react at room temperature for 2 h and quenched with water (10 mL). The organic phase was dried over anhydrous sodium sulfate. Silica gel column chromatography was performed using PE / DCM (V: V= 1:1) as the eluent to give the product BP[n]-CS7-2nOTf.
[0076] For BP[2]-CS7-4OTf: 1 H NMR (400 MHz, CDCl3, 298 K) δ 7.76 (dd, J =7.7, 1.6 Hz, 4H), 7.60 (d, J = 7.7 Hz, 4H), 7.44 – 7.36 (m, 4H), 6.93 (s, 4H), 4.13 (s, 4H), 3.87 (s, 12H). 19 F NMR (376 MHz, CDCl3, 298 K) δ -73.40. 13 CNMR (101 MHz, CDCl3, 298 K) δ 156.3, 147.2, 143.6, 137.9, 135.5, 135.3,133.2, 130.1, 125.3, 122.8, 120.44, 120.35, 117.3, 56.3, 29.9. HRMS (MALDI-TOF): m / z calcd for [BP[2]-CS7-4OTf] •+ , C 60 H 36 F 16 O 18 S4 •+ , 1400.0587, found1400.0586.
[0077] BP[2]-CS8-4OAc, NaOH, water (5.0 mL) and THF (20 mL) were added to a 50 mL flask. The reaction mixture was stirred at 85 °C for 2 h under argon protection. After cooling to room temperature, the solvent was removed under reduced pressure and diluted HCl (5%, 10 mL) was added to the flask. The mixture was extracted with DCM / EA and the organic phase was separated by simple column separation to obtain a mixture of BP[2]-CS8-4OH. Subsequently, the mixture BP[2]-CS8-4OH and pyridine (2.0 mL) were dissolved in DCM (30 mL) and trifluoromethanesulfonic anhydride (Tf2O, 1.6 mL) was added at 0 °C. The mixture was reacted at room temperature for 2 h and quenched by adding water (10 mL). The organic phase was dried over anhydrous sodium sulfate. The product BP[2]-CS8-4OTf was obtained by silica gel column chromatography using PE / DCM (V: V= 1:1) as the eluent.
[0078] For BP[2]-CS8-4OTf: 1 H NMR (400 MHz, CDCl3, 298 K) δ 7.81 (s, 4H),7.73 (d, J = 8.0 Hz, 8H), 7.65 (dd, J = 6.8, 3.3 Hz, 8H), 7.38 (d, J = 8.0Hz, 8H), 6.99 (dd, J = 6.9, 3.2 Hz, 8H), 6.75 (s, 4H), 3.91 (s, 12H), 3.84(s, 4H), 2.50 (s, 12H). HRMS (MALDI-TOF): m / z calcd for [BP[2]-CS8-4OTf] •+ ,C 86 H 56 F 12 O 16 S4 •+ , 1700.2254, found 1700.2239.
[0079] Ni(cod)2 (148 mg, 0.54 mmol) and 2, 2`-bipyridine (84.3 mg, 0.54 mmol) were added to a dry reaction tube. N-methyl-2-pyrrolidone (NMP, 6.0 mL) was added. Stir at room temperature for 45 minutes and in an oil bath at 85°C for 5 minutes. Then, a solution of BP[n]-CS1-2nOTf (0.02 mmol) in NMP (6.0 mL) was added and stirring was continued at 85°C for 4 to 24 hours. After the reaction was completed, the mixture was cooled to room temperature and poured into a mixture of saturated solutions of CH2Cl2 (30 ml) and NH4Cl (30 ml) and stirred vigorously for 10 minutes. After the organic layer was concentrated, silica gel column chromatography was performed with DCM / PE (2:1, v / v) as the eluent to obtain [m]CPP-CS1-2nOMe.
[0080] For [9]CPP-CS1- 6 OMe: 1 H NMR (400 MHz, CD2Cl2, 298 K) δ 7.42 (s, 12H), 7.15 (s, 6H), 6.91 (s, 6H), 3.90 (s, 18H), 3.52 (s, 6H). 13 C NMR (101 MHz, CD2Cl2, 298 K) δ 157.0, 142.3, 140.1, 139.9, 131.9, 128.3, 128.2, 105.3, 56.6,53.8, 30.1. HRMS (ESI): m / z calcd for [[9]CPP-CS1- 6 OMe] •+ , C 63 H 48 O6 •+ , 900.3445,found 900.3433; for [[9]CPP-CS1- 6 OMe + Na] + , C 63 H 48 O6Na + , 923.3343, found923.3348. For
[12] CPP-CS1-8OMe: 1H NMR (400 MHz, CD2Cl2, 298 K) δ 7.55 (s, 14H), 7.32 (s, 8H), 7.04 (s, 8H), 3.97 (s, 24H), 3.63 (s, 8H). MALDI-TOF-HRMS: m / z calcd for [
[12] CPP-CS1-8OMe] •+ , C 84 H 64 O8 •+ , 1200.4596, found 1200.4594. For
[15] CPP-CS1- 10 OMe: 1 H NMR (400 MHz, CD2Cl2, 298 K) δ 7.54 (s,20H), 7.35 (s, 10H), 7.14 (s, 10H), 3.96 (s, 30H), 3.63 (s, 10H). MALDI-TOF-HRMS: m / z calcd for [
[15] CPP-CS1- 10 OMe] •+ , C 105 H 80 O 10 •+ , 1500.5746, found1500.5743.
[0081] Ni(cod)2 (148 mg, 0.54 mmol) and 2, 2`-bipyridine (84.3 mg, 0.54 mmol) were added to a dry reaction tube. N-methyl-2-pyrrolidone (NMP, 6.0 mL) was added. Stir at room temperature for 45 minutes and in an oil bath at 85°C for 5 minutes. Then, a solution of BP[n]-CS2-2nOTf (0.02 mmol) in NMP (6.0 mL) was added and stirring was continued at 85°C for 4 to 24 hours. After the reaction was completed, the mixture was cooled to room temperature and poured into a mixture of saturated solutions of CH2Cl2 (30 ml) and NH4Cl (30 ml) and stirred vigorously for 10 minutes. After the organic layer was concentrated, silica gel column chromatography was performed with DCM / PE (2:1, v / v) as the eluent to obtain [m]CPP-CS2-2nOMe.
[0082] For [9]CPP-CS2- 6 OMe:1 H NMR (400 MHz, CDCl3, 298 K) 7.71 (d, J = 8.5Hz, 12H), 7.57 (d, J = 8.5 Hz, 12H), 7.34 (s, 6H), 7.03 (s, 6H), 4.04 (s,18H), 3.59 (s, 6H). MALDI-TOF-HRMS: m / z calcd for [[9]CPP-CS2- 6 OMe] •+ ,C 81 H 60 O6 •+ , 1128.4384, found 1128.4380.
[0083] Ni(cod)2 (148 mg, 0.54 mmol) and 2, 2`-bipyridine (84.3 mg, 0.54 mmol) were added to a dry reaction tube. N-methyl-2-pyrrolidone (NMP, 6.0 mL) was added. Stir at room temperature for 45 minutes and in an oil bath at 85°C for 5 minutes. Then, a solution of BP[n]-CS3-2nOTf (0.02 mmol) in NMP (6.0 mL) was added and stirring was continued at 85°C for 4 to 24 hours. After the reaction was completed, the mixture was cooled to room temperature and poured into a mixture of saturated solutions of CH2Cl2 (30 ml) and NH4Cl (30 ml) and stirred vigorously for 10 minutes. After the organic layer was concentrated, silica gel column chromatography was performed with DCM / PE (2:1, v / v) as the eluent to obtain [m]CPP-CS3-2nOMe.
[0084] For [6]CPP-CS3- 4 OMe: 1 H NMR (400 MHz, CDCl3, 298 K) δ 8.28 (dd, J =6.2, 3.3 Hz, 4H), 7.62 (s, 4H), 7.57 – 7.44 (m, 4H), 6.95 (d, J = 10.2 Hz,8H), 4.03 (s, 12H), 3.89 (d, J = 18.9 Hz, 2H), 3.10 (d, J = 19.1 Hz, 2H). MALDI-TOF-HRMS: m / z calcd for [[6]CPP-CS3- 4 OMe] •+ , C 50 H 36 O4 •+ , 700.2608, found700.2609. For [9]CPP-CS3- 6 OMe: 1 H NMR (400 MHz, CDCl3, 298 K) δ 8.32 (dd, J =6.4, 3.3 Hz, 6H), 7.50 (dd, J = 6.4, 3.3 Hz, 6H), 7.35 (s, 6H), 7.15 (s, 6H),6.89 (s, 6H), 4.02 (s, 18H), 3.70 (d, J = 20.6 Hz, 3H), 3.14 (d, J = 20.7 Hz,3H). 13 C NMR (101 MHz, CDCl3, 298 K) δ 157.1, 142.3, 138.8, 136.9, 133.3,131.5, 128.3, 127.9, 127.1, 125.6, 105.8, 56.9, 36.6. MALDI-TOF-HRMS: m / z calcd for [[9]CPP-CS3- 6 OMe] •+ , C 75 H 54 O6 •+ , 1050.3915, found 1050.3923. For
[12] CPP-CS3- 8 OMe: 1 H NMR (400 MHz, CDCl3, 298 K) δ 8.26 (dd, J =6.4, 3.3 Hz, 8H), 7.49 (dd, J = 6.4, 3.3 Hz, 8H), 7.47 (s, 8H), 7.28 (s, 8H),7.07 (s, 8H), 4.01 (s, 24H), 3.77 (d,J = 21.2 Hz, 4H), 3.32 (d, J = 21.3 Hz,4H). 13 C NMR (101 MHz, CDCl3, 298 K) δ 157.1, 142.2, 137.4, 136.4, 133.4,130.9, 128.7, 128.0, 127.0, 125.6, 105.1, 56.8, 29.9. MALDI-TOF-HRMS: m / z calcd for [[9]CPP-CS3- 6 OMe] •+ , C 75 H 54 O6 •+ , 1400.5222, found 1400.5212.
[0085] Ni(cod)2 (148 mg, 0.54 mmol) and 2, 2`-bipyridine (84.3 mg, 0.54 mmol) were added to a dry reaction tube. N-methyl-2-pyrrolidone (NMP, 6.0 mL) was added. Stir at room temperature for 45 minutes and in an oil bath at 85°C for 5 minutes. Then, a solution of BP[2]-CS2-4OTf (0.02 mmol) in NMP (6.0 mL) was added and stirring was continued at 85°C for 4 hours. After the reaction was completed, the mixture was cooled to room temperature and poured into a mixture of saturated CH2Cl2 (30 ml) and NH4Cl (30 ml) solutions and stirred vigorously for 10 minutes. After the organic layer was concentrated, silica gel column chromatography was performed with DCM / PE (2:1, v / v) as the eluent to obtain [8]CPP-CS4-4OMe.
[0086] For [8]CPP-CS4- 4 OMe: 1H NMR (400 MHz, CD2Cl2, 298 K) δ 7.54 (d, J =8.2 Hz, 4H), 7.41 (d, J = 8.1 Hz, 4H), 7.17 (s, 4H), 7.14 (s, 4H), 6.64 (s,4H), 3.92 (s, MALDI-TOF-HRMS: m / z calcd for [[8]CPP-CS4- 4 OMe] •+ , C 56 H 40 O4 •+ , 776.2921, found 776.2918.
[0087] Ni(cod)2 (148 mg, 0.54 mmol) and 2, 2'-bipyridine (84.3 mg, 0.54 mmol) were added to a dry reaction tube. N-methyl-2-pyrrolidone (NMP, 6.0 mL) was added. Stir at room temperature for 45 minutes and in an oil bath at 85°C for 5 minutes. Then, a solution of BP[2]-CS5-4OTf (0.02 mmol) in NMP (6.0 mL) was added and stirring was continued at 85°C for 4 hours. After the reaction was completed, the mixture was cooled to room temperature and poured into a mixture of saturated solutions of CH2Cl2 (30 ml) and NH4Cl (30 ml) and stirred vigorously for 10 minutes. After the organic layer was concentrated, it was separated by silica gel column chromatography using DCM / PE (2:1, v / v) as the eluent to obtain [8]CPP-CS5-4OMe.
[0088] For [8]CPP-CS5-4OMe: 1 H NMR (400 MHz, CDCl3, 298 K) δ 7.91 (d, J = 8.5Hz, 4H), 7.63 (d, J = 1.3 Hz, 4H), 7.55 (dd, J= 8.5, 1.5 Hz, 4H), 7.19 (s,4H), 6.66 (s, 4H), 4.05 (s, 12H), 3.78 (d, J = 19.9 Hz, 2H), 3.12 (d, J =19.9 Hz, 2H). 13 C NMR (101 MHz, CDCl3, 298 K) δ 156.4, 142.2, 142.0, 140.6,137.8, 135.3, 132.9, 127.7, 127.2, 123.0, 122.6, 105.4, 56.6, 37.6. MALDI-TOF-HRMS: m / z calcd for [[8]CPP-CS5-4OMe] •+ , C 54 H 36 O4S2 •+ , 812.2050, found812.2046.
[0089] Ni(cod)2 (148 mg, 0.54 mmol) and 2, 2`-bipyridine (84.3 mg, 0.54 mmol) were added to a dry reaction tube. N-methyl-2-pyrrolidone (NMP, 6.0 mL) was added. Stir at room temperature for 45 minutes and in an oil bath at 85°C for 5 minutes. Then, a solution of BP[2]-CS6-4OTf (0.02 mmol) in NMP (6.0 mL) was added and stirring was continued at 85°C for 4 hours. After the reaction was completed, the mixture was cooled to room temperature and poured into a mixture of saturated CH2Cl2 (30 ml) and NH4Cl (30 ml) solutions and stirred vigorously for 10 minutes. After the organic layer was concentrated, it was separated by silica gel column chromatography using DCM / PE (2:1, v / v) as the eluent to obtain [8]CPP-CS6-4OMe.
[0090] For [8]CPP-CS6-4OMe: 1 H NMR (400 MHz, CDCl3, 298 K) 7.71 (d, J = 8.5Hz, 12H), 7.57 (d, J= 8.5 Hz, 12H), 7.34 (s, 6H), 7.03 (s, 6H), 4.04 (s,18H), 3.59 (s, 6H). MALDI-TOF-HRMS: m / z calcd for [[8]CPP-CS6-4OMe] •+ ,C 54 H 36 O6 •+ , 780.2506, found 780.2506.
[0091] Ni(cod)2 (148 mg, 0.54 mmol) and 2, 2`-bipyridine (84.3 mg, 0.54 mmol) were added to a dry reaction tube. N-methyl-2-pyrrolidone (NMP, 6.0 mL) was added. Stir at room temperature for 45 minutes and in an oil bath at 85°C for 5 minutes. Then, a solution of BP[2]-CS7-4OTf (0.02 mmol) in NMP (6.0 mL) was added and stirring was continued at 85°C for 12 hours. After the reaction was completed, the mixture was cooled to room temperature and poured into a mixture of saturated CH2Cl2 (30 ml) and NH4Cl (30 ml) solutions and stirred vigorously for 10 minutes. After the organic layer was concentrated, it was separated by silica gel column chromatography using DCM / PE (2:1, v / v) as the eluent to obtain [8]CPP-CS7-4OMe.
[0092] For [8]CPP-CS7-4OMe: 1 H NMR (400 MHz, CDCl3, 298 K) δ 7.59 (d, J = 8.0Hz, 4H), 7.38 (d, J = 8.0 Hz, 4H), 7.34 (s, 4H), 7.20 (s, 4H), 6.74 (s, 4H), 4.02 (s, 12H), 3.81 (d, J = 19.8 Hz, 2H), 3.21 (d, J = 20.0 Hz, 2H). 13C NMR(101 MHz, CDCl3, 298 K) δ 194.4, 156.8, 143.2, 143.1, 142.1, 140.0, 135.9,131.7, 130.9, 128.7, 127.6, 122.6, 104.7, 56.2, 37.4. MALDI-TOF-HRMS: m / z calcd for [[8]CPP-CS7-4OMe + Na] + , C 56 H 36 O6Na + , 827.2404, found 827.2400.
[0093] Ni(cod)2 (148 mg, 0.54 mmol) and 2, 2`-bipyridine (84.3 mg, 0.54 mmol) were added to a dry reaction tube. N-methyl-2-pyrrolidone (NMP, 6.0 mL) was added. Stir at room temperature for 45 minutes and in an oil bath at 85°C for 5 minutes. Then, a solution of BP[2]-CS8-4OTf (0.02 mmol) in NMP (6.0 mL) was added and stirring was continued at 85°C for 12 hours. After the reaction was completed, the mixture was cooled to room temperature and poured into a mixture of saturated CH2Cl2 (30 ml) and NH4Cl (30 ml) solutions and stirred vigorously for 10 minutes. After the organic layer was concentrated, it was separated by silica gel column chromatography using DCM / PE (2:1, v / v) as the eluent to obtain
[10] CPP-CS8-4OMe.
[0094] For
[10] CPP-CS8-4OMe: 1 H NMR (400 MHz, CDCl3, 298 K) δ 7.70 (d, J =8.1 Hz, 8H), 7.40 (dd, J = 6.5, 3.0 Hz, 8H), 7.35 (d, J = 4.7 Hz, 8H), 7.33(s, 4H), 7.22 (s, 4H), 7.14 (dd, J = 6.8, 3.2 Hz, 8H), 4.08 (s, 12H), 3.82(s, 4H). HRMS (MALDI-TOF): m / z calcd for [
[10] CPP-CS8-4OMe]•+ , C 82 H 56 O4 •+ ,1104.4173, found 1104.4168.
[0095] Add two monomers (150 mg each), paraformaldehyde (70 mg), and dichloromethane (50 mL) to a 250 mL round-bottom flask, add boron trifluoride etherate under stirring, and react at room temperature for 2 h. Add saturated sodium bicarbonate solution to quench, extract with dichloromethane, dry the organic phase with anhydrous sodium sulfate, concentrate under reduced pressure, separate by silica gel column chromatography, and set aside. Then, add the above crude product, sodium hydroxide (110 mg), purified water (0.3 mL), and tetrahydrofuran (8 mL) to a 25 mL round-bottom flask, and heat under reflux at 90°C for 2.5 h. Concentrate under reduced pressure, add water, concentrated HCl (2 mL), extract with ethyl acetate, dry the organic phase with anhydrous sodium sulfate, concentrate under reduced pressure, separate by silica gel column chromatography, add the obtained solid to a 50 mL round-bottom flask, add ultra-dry dichloromethane (10 mL), stir for 10 min in an ice-water bath, add pyridine (1.5 mL), slowly add trifluoromethanesulfonic anhydride (1.2 mL), move to room temperature and react for 1 h. Slowly add water to quench, extract with dichloromethane, dry the organic phase with anhydrous sodium sulfate, concentrate under reduced pressure, separate by silica gel column chromatography, and obtain a mixture of trifluoromethylsulfonyl ester functionalized biphenyl aromatic macrocycles for use. Finally, add Ni(cod)2 (148 mg, 0.54 mmol) and 2, 2'-bipyridine (84.3 mg, 0.54 mmol) to the dry reaction tube. Add N-methyl-2-pyrrolidone (NMP, 6.0 mL). Stir at room temperature for 45 minutes and in an oil bath at 85°C for 5 minutes. Then, a solution of a mixture of trifluoromethylsulfonyl ester-functionalized biphenyl aromatic macrocycles (0.02 mmol) in NMP (6.0 mL) was added and stirring was continued at 85°C for 12 hours. After the reaction was completed, the mixture was cooled to room temperature and poured into a mixture of saturated CH2Cl2 (30 ml) and NH4Cl (30 ml) solutions and stirred vigorously for 10 minutes. After the organic layer was concentrated, it was separated by silica gel column chromatography using DCM / PE (2:1, v / v) as the eluent to obtain H-[9]CPP-1 and H-[9]CPP-2.
[0096] For H-[9]CPP-1: 1 H NMR (400 MHz, CDCl3, 298 K) δ 8.34 (dd, J<h2 style=";text-align:left;direction:ltr">= 6.4,3.3 Hz, 2H), 7.53 (dd,<h2 style=";text-align:left;direction:ltr"> J <h2 style=";text-align:left;direction:ltr"> = 6.4, 3.3 Hz, 2H), 7.48 (s, 8H), 7.31 (s, 2H), 7.24 (s, 2H), 7.19 (s, 2H), 7.13 (s, 2H), 6.94 (s, 2H), 6.93 (s, 4H), 4.00 (s,12H), 3.98 (s, 6H), 3.78 (d,<h2 style=";text-align:left;direction:ltr"> J <h2 style=";text-align:left;direction:ltr"> = 20.5 Hz, 3H), 3.43 (d,<h2 style=";text-align:left;direction:ltr"> J <h2 style=";text-align:left;direction:ltr"> = 20.5 Hz, 1H),3.27 (d,<h2 style=";text-align:left;direction:ltr"> J <h2 style=";text-align:left;direction:ltr"> = 20.6 Hz, 2H).<h2 style=";text-align:left;direction:ltr"> 13 <h2 style=";text-align:left;direction:ltr"> C NMR (101 MHz, CDCl3, 298 K) δ 157.13, 156.56,142.44, 141.92, 141.84, 139.70, 139.63, 139.38, 139.01, 136.85, 133.31,131.93, 131.81, 131.48, 128.16, 128.13, 128.02, 127.84, 127.11, 125.59,105.98, 105.10, 104.96, 77.16, 56.96, 56.52, 37.00, 36.78.<h2 style=";text-align:left;direction:ltr"> <h2 style=";text-align:left;direction:ltr"> For H-[9]CPP-2:<h2 style=";text-align:left;direction:ltr"> 1 <h2 style=";text-align:left;direction:ltr"> H NMR (400 MHz, CDCl3, 298 K) δ 8.33 (tq,<h2 style=";text-align:left;direction:ltr"> J <h2 style=";text-align:left;direction:ltr"> = 6.8,3.5 Hz, 4H), 7.55 – 7.49 (m, 4H), 7.45 (s, 4H), 7.35 (s, 2H), 7.31 (s, 2H),7.23 (s, 2H), 7.15 (s, 4H), 6.93 (s, 2H), 6.90 (s, 4H), 4.02(s, 6H), 4.00(s, 6H), 3.99(s, 6H), 3.77(d,<h2 style=";text-align:left;direction:ltr"> J <h2 style=";text-align:left;direction:ltr"> = 20.3 Hz, 2H), 3.72 (d,<h2 style=";text-align:left;direction:ltr"> J <h2 style=";text-align:left;direction:ltr"> = 18.4 Hz, 1H),3.26 (d,<h2 style=";text-align:left;direction:ltr"> J <h2 style=";text-align:left;direction:ltr"> = 20.6 Hz, 2H), 3.16 (d,<h2 style=";text-align:left;direction:ltr"> J <h2 style=";text-align:left;direction:ltr"> = 20.8 Hz, 1H).<h2 style=";text-align:left;direction:ltr"> 13C NMR (101 MHz, CDCl3,298 K) δ 157.11, 156.50, 142.44, 142.32, 141.86, 139.72, 139.44, 139.05,138.74, 136.88, 136.74, 133.35, 133.23, 131.98, 131.47, 128.49, 128.36,128.07, 128.01, 127.94, 127.10, 127.08, 125.60, 105.97, 105.80, 104.95,77.16, 56.93, 56.52, 36.79, 36.56.
[0097] Add the functional conjugated nanoring containing a cycloparaphenylene skeleton (5.0 mg) to a 10 mL reaction tube, seal it, add ultra-dry dichloromethane with a syringe, then add boron tribromide (0.5 mL), and react at room temperature for 3 h. Quench the reaction with distilled water, dry the organic phase with anhydrous sodium sulfate, concentrate under reduced pressure, and separate it by silica gel column chromatography to obtain a crude product for use. Add the crude product to a 10 mL round-bottom flask, add ethyl bromoacetate, acetonitrile and potassium carbonate in sequence, seal it, reflux for 3 hours, and separate it by column to obtain the ester-modified conjugated nanoring [9]CPP-CS1-6CH2COOEt.
[0098] For [9]CPP-CS1-6CH2COOEt: 1 H NMR (400 MHz, CDCl3, 298 K) δ 7.62 (s,12H), 7.14 (s, 6H), 6.98 (s, 6H), 4.78 (s, 12H), 4.26 (dd, J = 14.2, 7.1 Hz,12H), 3.59 (s, 6H), 1.29 (t, J = 7.1 Hz, 18H). 13C NMR (101 MHz, CDCl3, 298K) 13 C NMR (101 MHz, CDCl3) δ 169.26, 154.97, 141.67, 140.80, 139.44, 132.11,128.65, 128.12, 107.99, 77.16, 67.45, 61.47, 31.08, 14.33. HRMS (MALDI-TOF): m / zcalcd for [[9]CPP-CS1-6CH2COOEt] •+ , C 81 H 72 O 18 •+ , 1332.4713, found 1332.4708. Example
[0099]
[0100] Molecular recognition of C60 by conjugated nanoring
[10] CPP-CS8-4OMe Using H NMR, C60 and
[10] CPP-CS8-4OMe were mixed in a ratio of 1:1 and tested (see Appendix Figure 2 The study found that
[10] the protons on CPP-CS8-4OMe (see Appendix Figure 2 The low-field shift of
[10] CPP-CS8-4OMe and C60 was observed. Figure 3 ), quantitatively studied the complex constant of
[10] CPP-CS8-4OMe and C60, where the complex constant is 9.0 × 10 3 M -1 .
[0101] Molecular recognition of C70 by conjugated nanoring
[10] CPP-CS8-4OMe Using H NMR, C70 and
[10] CPP-CS8-4OMe were mixed in a ratio of 1:1 and tested (see Appendix Figure 2 The study found that
[10] the protons on CPP-CS8-4OMe (see Appendix Figure 2 The low-field shift of
[10] CPP-CS8-4OMe and C70 was observed. Figure 4 ), quantitatively studied the complex constant of
[10] CPP-CS8-4OMe and C60, where the complex constant is 2.3 × 10 4 M -1 .
[0102] Conclusion:
[10] CPP-CS8-4OMe has stronger complexing ability with C70.
Claims
1. A series of functional conjugated nanorings containing cycloparaphenylene skeletons, Features Includes the following structure: (1) A series of acetoxy-substituted polyphenyl monomer molecules; (2) A series of acetoxy-substituted biphenyl aromatic macrocycles; (3) A series of biphenyl aromatic macrocycles functionalized with trifluoromethylsulfonyl esters; (4) A series of functional conjugated nanorings containing a cycloparaphenylene skeleton; It has the following structure: x is 1-8; in: When it is CS1, n = 0 ~ 4; when it is CS2, n = 1 ~ 5; when it is CS3, n = 0 ~ 2; when it is CS4, n = 0 ~2; when it is CS5, n = 0 ~ 2; when it is CS6, n = 0 ~ 1; when it is CS7, n = 0 ~ 1; when it is CS8, n = 0; in: (1) The molecular structure of a series of acetoxy-substituted polyphenyl monomers is as follows: ; (2) A series of acetoxy-substituted biphenyl aromatic macrocycles ; (3) A series of trifluoromethylsulfonyl ester-functionalized biphenyl aromatic macrocycles ; (4) A series of functional conjugated nanorings containing cycloparaphenylene skeletons 。 2. A method for preparing the series of functional conjugated nanorings containing a cycloparaphenylene skeleton as claimed in claim 1, Features: (1) The synthesis method of acetoxy-substituted polyphenyl monomer molecules is as follows: Add 4-bromo-3-methoxyphenol (60.91 g), N, N-dimethylformamide (200 mL), pyridine (35 mL) and acetyl chloride (28 mL) to a 500 mL two-necked flask and react at room temperature for 3 hours. After quenching with water, extract with dichloromethane, wash the organic phase with water three times, dry the organic phase with anhydrous sodium sulfate, and concentrate under reduced pressure. Mix the sample with silica gel and separate it by silica gel column chromatography to obtain 2-bromo-5-acetoxyanisole as a white solid (66.1 g); In a 250 mL round-bottom flask, aryl diboronic acid bis(pinacol ester) (4.06 g), 2-bromo-5-acetoxyanisole (5.12 g), Pd(dppf)Cl 2 (1.00 g), K 2 CO 3 (5.25 g), 1, 4-dioxane (80 mL), H 2 O (20 mL), reflux at 105 °C for 48 h under argon protection. Remove the solvent under reduced pressure and concentrate, add ultra-dry DMF (50 mL), pyridine (6.0 mL) and acetyl chloride (4.8 mL) to the reaction system, and react at room temperature for 2 h. Add water to quench, extract with dichloromethane, dry the organic phase with anhydrous sodium sulfate, concentrate under reduced pressure, mix with silica gel, and purify with silica gel column chromatography to obtain the monomer as a white solid; (2) The synthesis method of acetoxy-substituted biphenyl aromatic macrocycle is as follows: Add the monomer (800 mg), paraformaldehyde (70 mg), and dichloromethane (100 mL) to a 250 mL round-bottom flask, add boron trifluoride etherate (2 mL) under stirring, and react at room temperature for 2 h. After quenching with saturated sodium bicarbonate solution, extract with dichloromethane, dry the organic phase with anhydrous sodium sulfate, concentrate under reduced pressure, and separate by silica gel column chromatography to obtain three-membered ring, four-membered ring, five-membered ring, six-membered ring, and seven-membered ring, all of which are white solids; (3) The synthesis method of a series of trifluoromethylsulfonyl ester functionalized biphenyl aromatic macrocycles is as follows: Add acetoxy-substituted biphenyl aromatic macrocycle (130 mg), sodium hydroxide (110 mg), purified water (0.3 mL), tetrahydrofuran (8 mL) to a 25 mL round-bottom flask and heat to reflux at 90°C for 2.5 h. Concentrate under reduced pressure and separate by silica gel column chromatography. Add the obtained solid to a 50 mL round-bottom flask, then add dichloromethane (10 mL), pyridine (1.5 mL) and trifluoromethanesulfonic anhydride (1.2 mL), and move to room temperature to react for 1 h. Slowly add water to quench, extract with dichloromethane, dry the organic phase with anhydrous sodium sulfate, separate by silica gel column chromatography, and obtain trifluoromethylsulfonyl ester functionalized biphenyl aromatic macrocycle as a white solid; (4) The efficient synthesis method of a series of functional conjugated nanorings containing a cycloparaphenylene skeleton is as follows: Add nickel catalyst, 2, 2'-bipyridine and N-methylpyrrolidone (20 mL) to a 50 mL reaction tube. Heat at 85°C, add trifluoromethylsulfonyl ester functionalized biphenyl aromatic macrocycle, and react for 4 to 12 hours. Cool the reaction to room temperature, extract with dichloromethane and distilled water, dry the organic phase with anhydrous sodium sulfate, concentrate under reduced pressure, and separate by silica gel column chromatography to obtain functional conjugated nanorings containing a cycloparaphenylene skeleton; (5) The efficient post-modification synthesis method of functional conjugated nanorings containing a cycloparaphenylene skeleton is as follows: Add the functional conjugated nanoring containing the cycloparaphenylene skeleton and dichloromethane (5 mL) to a 10 mL reaction tube, then add boron tribromide and react at room temperature for 3 h. Quench the reaction with distilled water, dry the organic phase with anhydrous sodium sulfate, concentrate under reduced pressure, and separate it by silica gel column chromatography to obtain a crude product for use. Add the crude product to a 10 mL round-bottom flask, add ethyl bromoacetate and potassium carbonate in sequence, reflux for 3 hours, and separate the ester-modified conjugated nanoring by column chromatography.
3. Use of the series of functional conjugated nanorings containing cycloparaphenylene skeletons as claimed in claim 1 for selective molecular recognition of C60 and C70.
